0,973  0,001  CYP2C9 substrate
0,958  0,002  CYP2D6 substrate
0,956  0,003  CYP1A2 substrate
0,950  0,003  Transcription factor NF kappa B inhibitor
0,946  0,003  CYP2C19 substrate
0,943  0,003  Cardiotonic
0,937  0,005  Apoptosis agonist
0,933  0,002  UGT1A6 substrate
0,917  0,004  Antineoplastic (lung cancer)
0,904  0,005  Antineoplastic (breast cancer)
0,902  0,004  CYP3A4 substrate
0,890  0,004  Teratogen
0,886  0,004  Antineoplastic (ovarian cancer)
0,885  0,004  Embryotoxic
0,878  0,005  Antineoplastic (colorectal cancer)
0,875  0,002  UGT1A1 substrate
0,870  0,004  Analeptic
0,870  0,004  Respiratory analeptic
0,870  0,005  Antineoplastic (colon cancer)
0,861  0,004  Chemopreventive
0,853  0,005  Carcinogenic
0,849  0,004  Prostate cancer treatment
0,843  0,003  Proliferative diseases treatment
0,835  0,002  Anesthetic
0,835  0,004  Antineoplastic (cervical cancer)
0,832  0,004  Heart failure treatment
0,829  0,003  Antineoplastic (sarcoma)
0,817  0,004  Antineoplastic (glioma)
0,814  0,007  TNF expression inhibitor
0,801  0,004  NOS2 expression inhibitor
0,796  0,004  Antineoplastic (pancreatic cancer)
0,777  0,005  Antineoplastic (non-small cell lung cancer)
0,772  0,003  Diuretic
0,768  0,003  Anesthetic general
0,757  0,005  Cytotoxic
0,756  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,753  0,004  UDP-glucuronosyltransferase substrate
0,750  0,004  Antineoplastic (renal cancer)
0,751  0,005  Antineoplastic (melanoma)
0,750  0,009  Antileukemic
0,722  0,004  UGT1A4 substrate
0,673  0,005  Antineoplastic (glioblastoma multiforme)
0,667  0,005  Antineoplastic (brain cancer)
0,663  0,004  Antineoplastic (liver cancer)
0,664  0,010  Sensitization
0,679  0,035  Antiinflammatory
0,628  0,009  NOS3 expression inhibitor
0,631  0,015  Cholesterol antagonist
0,621  0,007  DNA damaging
0,615  0,005  Antineoplastic (lymphoma)
0,612  0,005  Antineoplastic (carcinoma)
0,587  0,000  Na+ K+ transporting ATPase inhibitor
0,602  0,017  Antihypercholesterolemic
0,594  0,012  Cytostatic
0,583  0,004  Transcription factor STAT3 inhibitor
0,583  0,005  P-glycoprotein inhibitor
0,580  0,007  Antineoplastic enhancer
0,584  0,011  Caspase 3 stimulant
0,579  0,011  Nitric oxide antagonist
0,578  0,013  Hepatic disorders treatment
0,565  0,005  Antineoplastic (squamous cell carcinoma)
0,575  0,016  Immunosuppressant
0,559  0,005  Transcription factor STAT inhibitor
0,556  0,013  Antiparasitic
0,541  0,014  Antineoplastic (multiple myeloma)
0,525  0,004  Neurotrophic factor enhancer
0,530  0,009  Antihelmintic
0,525  0,005  Contraceptive
0,534  0,018  Cardioprotectant
0,536  0,023  Antipruritic, allergic
0,516  0,003  ATPase inhibitor
0,517  0,005  Antidiarrheal
0,524  0,019  CYP2C19 inhibitor
0,502  0,010  UGT2B4 substrate
0,539  0,047  Caspase 9 stimulant
0,495  0,004  Androgen antagonist
0,493  0,005  UGT2B7 substrate
0,498  0,011  Antineoplastic (endocrine cancer)
0,497  0,012  ICAM1 expression inhibitor
0,498  0,021  Lipoprotein disorders treatment
0,478  0,005  Sodium/bile acid cotransporter inhibitor
0,471  0,008  UGT1A3 substrate
0,445  0,006  Lipocortins synthesis antagonist
0,448  0,009  Abortion inducer
0,441  0,004  Contraceptive male
0,462  0,026  AR expression inhibitor
0,457  0,030  Antifungal
0,440  0,016  Antihypoxic
0,449  0,027  Antihypertensive
0,441  0,020  Cardiodepressant
0,470  0,050  Antibacterial
0,455  0,036  Bone diseases treatment
0,480  0,063  Antineoplastic (solid tumors)
0,441  0,027  UGT1A9 substrate
0,417  0,005  UGT2B1 substrate
0,431  0,020  Hypolipemic
0,433  0,026  Mutagenic
0,417  0,012  Hepatoprotectant
0,411  0,010  Prostate disorders treatment
0,405  0,004  UGT2B9 substrate
0,407  0,008  UGT2B15 substrate
0,419  0,020  Antimitotic
0,421  0,024  Antipyretic
0,395  0,011  Antipruritic, non-allergic
0,382  0,005  Cholesterol synthesis inhibitor
0,409  0,036  Apoptosis antagonist
0,402  0,030  Cardiovascular analeptic
0,367  0,009  Adenylate cyclase inhibitor
0,370  0,017  Antiviral (Herpes)
0,364  0,015  Prostatic (benign) hyperplasia treatment
0,368  0,019  Muscle relaxant
0,387  0,043  Spasmolytic
0,371  0,044  Antiosteoporotic
0,369  0,041  Antioxidant
0,330  0,009  Antihyperlipoproteinemic
0,335  0,022  Antiviral (Influenza)
0,343  0,031  Antineoplastic (lymphocytic leukemia)
0,345  0,041  Antineoplastic (osteosarcoma)
0,316  0,018  Interferon gamma antagonist
0,290  0,007  Farnesoid X receptor antagonist
0,321  0,042  Angiogenesis stimulant
0,295  0,023  Antiacne
0,287  0,018  Antiviral (Influenza A)
0,319  0,052  Chemoprotective
0,334  0,069  Immunostimulant
0,268  0,005  Microtubule formation inhibitor
0,260  0,004  Androgen agonist
0,304  0,053  Antiprotozoal (Leishmania)
0,253  0,004  Antineoplastic alkaloid
0,267  0,025  Hair growth stimulant
0,254  0,012  UGT2B10 substrate
0,261  0,024  Protein kinase stimulant
0,241  0,007  Aromatase inhibitor
0,239  0,005  Pregnane X receptor agonist
0,238  0,009  Arachidonic acid antagonist
0,244  0,016  VEGF expression inhibitor
0,233  0,008  Hedgehog signaling inhibitor
0,235  0,011  Choleretic
0,217  0,004  Glycine receptor agonist
0,216  0,003  Anabolic
0,295  0,082  CYP3A4 inhibitor
0,264  0,058  DNA synthesis inhibitor
0,231  0,027  Interleukin 6 antagonist
0,244  0,050  VCAM1 expression inhibitor
0,202  0,009  Actinic keratosis treatment
0,194  0,004  Potassium channel Kv1.3 blocker
0,217  0,032  Toxic, respiratory center
0,188  0,005  Progesterone antagonist
0,249  0,069  Vasodilator
0,184  0,009  Estrogen agonist
0,261  0,086  Radioprotector
0,193  0,019  Growth stimulant
0,184  0,011  ABCA1 expression enhancer
0,176  0,004  Anticholelithogenic
0,270  0,098  Interleukin 2 agonist
0,176  0,005  Bile acid receptor antagonist
0,187  0,016  Contraceptive female
0,189  0,018  Sulfotransferase substrate
0,177  0,007  UGT2B11 substrate
0,189  0,020  Adenylate cyclase stimulant
0,231  0,063  RNA-directed DNA polymerase inhibitor
0,229  0,062  Antiarrhythmic
0,246  0,082  Interleukin agonist
0,192  0,028  Topoisomerase I inhibitor
0,165  0,004  RNA-directed RNA polymerase stimulant
0,195  0,034  Antifungal enhancer
0,156  0,006  Glycine receptor antagonist
0,194  0,045  Antirickettsial
0,166  0,023  Antineoplastic, alkylator
0,191  0,050  Phospholipase C inhibitor
0,167  0,027  Antineoplastic antibiotic
0,175  0,036  Protein-tyrosine phosphatase 1B inhibitor
0,196  0,060  Growth hormone agonist
0,160  0,031  Endometrios treatment
0,165  0,039  Alkylator
0,138  0,013  Postmenopausal disorders treatment
0,189  0,064  LDLR expression enhancer
0,144  0,026  Estrogen antagonist
0,153  0,035  Ca2+-transporting ATPase inhibitor
0,201  0,083  Antihypertriglyceridemic
0,257  0,139  Calcium channel activator
0,172  0,058  Melanin inhibitor
0,149  0,036  Expectorant
0,156  0,043  Cyclooxygenase 3 inhibitor
0,185  0,079  Growth factor agonist
0,122  0,018  Estrogen receptor alpha antagonist
0,126  0,023  Transcription factor NF kappa B stimulant
0,128  0,025  SULT1E1 substrate
0,182  0,081  Platelet adhesion inhibitor
0,153  0,054  Psychosexual dysfunction treatment
0,171  0,075  Antineoplastic (bone cancer)
0,104  0,008  H+/K+-transporting ATPase inhibitor
0,134  0,046  Alcohol dehydrogenase substrate
0,096  0,010  5-Alpha-reductase inhibitor
0,090  0,004  Microtubule stabilization
0,095  0,009  Estrogen receptor alpha agonist
0,111  0,026  ATPase (Vacuolar H+) inhibitor
0,090  0,007  Acetyl-CoA transferase 2 inhibitor
0,091  0,008  Lipocortins synthesis agonist
0,137  0,054  Antiviral (Hepatitis B)
0,155  0,073  Protein-tyrosine phosphatase inhibitor
0,139  0,058  Antihemorrhagic
0,113  0,033  Acetylcholine nicotinic antagonist
0,235  0,157  Ulceration
0,078  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,077  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,143  0,071  Skeletal muscle relaxant
0,130  0,061  DNA polymerase I inhibitor
0,071  0,007  Farnesoid X receptor agonist
0,109  0,048  Estrogen receptor beta antagonist
0,106  0,047  Lanosterol 14 alpha demethylase inhibitor
0,123  0,065  Anesthetic local
0,204  0,146  Antimycobacterial
0,100  0,044  Ornithine decarboxylase inhibitor
0,080  0,024  SULT2A1 substrate
0,093  0,041  Antiprotozoal activity enhancer
0,068  0,016  Estrogen receptor beta agonist
0,090  0,038  Keratolytic
0,173  0,121  Free radical scavenger
0,062  0,011  Glucocorticoid antagonist
0,126  0,077  Skin whitener
0,055  0,005  HMG CoA reductase inhibitor
0,070  0,021  Postcoital contraceptive
0,169  0,121  Antialcoholic
0,138  0,090  Eye irritation, high
0,085  0,038  CDC25A inhibitor
0,053  0,008  Cholesterol absorption inhibitor
0,085  0,042  Antibiotic
0,123  0,082  Liver cirrhosis treatment
0,103  0,065  Toll-Like receptor 4 antagonist
0,044  0,006  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,052  0,014  Hypogonadism treatment
0,107  0,070  SULT1A1 substrate
0,105  0,071  Mucolytic
0,045  0,011  Tubulin agonist
0,055  0,022  Estradiol 17 beta-dehydrogenase inhibitor
0,053  0,020  Liver X receptor agonist
0,100  0,070  Antiinfertility, female
0,060  0,030  Protein 50S ribosomal subunit inhibitor
0,067  0,037  Nitric oxide donor
0,034  0,007  Hedgehog signaling activator
0,030  0,007  Progesterone agonist
0,141  0,119  Wound healing agent
0,047  0,026  Opioid kappa receptor agonist
0,025  0,004  Vitamin D receptor agonist
0,061  0,043  Heme oxygenase stimulant
0,102  0,085  Carcinogenic, group 3
0,026  0,009  Corticosteroid-like
0,057  0,042  Botulinum neurotoxin type A inhibitor
0,021  0,006  Telomerase stimulant
0,051  0,036  Anesthetic inhalation
0,045  0,033  Parathyroid hormone antagonist
0,047  0,036  Mineralocorticoid receptor antagonist
0,083  0,074  Paget's disease treatment
0,092  0,083  HDL-cholesterol increasing
0,193  0,186  Antithrombotic
0,026  0,021  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,021  0,017  Vitamin D receptor antagonist
0,069  0,065  SULT1A2 substrate
0,006  0,004  Transcortin receptor antagonist
0,017  0,016  Apical sodium codependent bile acid transporter inhibitor
0,108  0,107  Lipid peroxidase inhibitor

